Results 131 to 140 of about 9,065 (221)

Discovery of Ruthenium(II) Metallocompound and Olaparib Synergy for Cancer Combination Therapy. [PDF]

J Med Chem, 2023
Yusoh NA, Tiley PR, James SD, Harun SN, Thomas JA, Saad N, Hii LW, Chia SL, Gill MR, Ahmad H.   +9 more
europepmc   +1 more source

Model for identifying regions' potential for clustering using information extraction tools and techniques. [PDF]

Sci Rep
Toprak A, Çetinyokuş T.
europepmc   +1 more source

MOB2 Loss Sensitizes Lung Cancer Cells to PARP Inhibition Through p53-Dependent DNA Damage Signaling. [PDF]

Curr Issues Mol Biol
Gundogdu R.
europepmc   +1 more source

Mapping and engaging the Costa Rican scientific diaspora: experiences from over a decade implementing the hipatia.cr portal. [PDF]

Front Res Metr Anal
Duran-Monge E, Santos M.
europepmc   +1 more source

Combination therapy overcomes secondary PARPi resistance in ATM-deficient prostate cancer. [PDF]

NPJ Precis Oncol
Arce-Gallego S, Esquefa V, Domenech H, Salca A, Aguilar D, Casals T, Mir G, Simonetti S, Oliveira A, de Llobet L, Neeb A, Brandariz J, Anselmino N, Casanova-Salas I, Herranz N, Serra V, de Bono JS, Mateo J.   +17 more
europepmc   +1 more source

αKG-mediated carnitine synthesis drives DNA repair via histone acetylation. [PDF]

Nature
Uboveja A, Yang B, Buj R, Amalric A, Wang H, Tangudu NK, Cole AR, Disharoon JA, Fang RS, Levasseur E, Naruse M, Huang Z, Megill E, Kantner DS, Chatoff A, Ahmad H, Marcinkiewicz MM, Graff S, De Pieri E, Huacachino AA, Vendetti FP, Danielson J, Dahl ES, Pennise JL, Elishaev E, Jaccard A, Borho L, Post MD, Cooper K, Modugno F, Hempel N, Stallaert W, Bakkenist CJ, Sidoli S, Wellen KE, Bitler BG, Long DT, Snyder NW, Aird KM.   +38 more
europepmc   +1 more source

A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer. [PDF]

J Exp Clin Cancer Res
Calheiros J, Silva R, Barbosa F, Morais J, Moura SR, Almeida S, Fiorini E, Mulhovo S, Aguiar TQ, Wang T, Ricardo S, Almeida MI, Domingues L, Melo SA, Corbo V, Ferreira MU, Saraiva L.   +16 more
europepmc   +1 more source

Temozolomide Sensitizes ARID1A-Mutated Cancers to PARP Inhibitors. [PDF]

Cancer Res, 2023
Yu ZC, Li T, Tully E, Huang P, Chen CN, Oberdoerffer P, Gaillard S, Shih IM, Wang TL.   +8 more
europepmc   +1 more source

Computationally-designed aptamers targeting RAD51-BRCA2 interaction impair homologous recombination and induce synthetic lethality. [PDF]

Nat Commun
Milordini G, Zacco E, Masi M, Armaos A, Di Palma F, Oneto M, Gilodi M, Rupert J, Broglia L, Varignani G, Scotto M, Marotta R, Girotto S, Cavalli A, Tartaglia GG.   +14 more
europepmc   +1 more source

Recalculation of the late fetal death rate in Mexico, 2013-2023 using ICD-11 criteria applied to national vital statistics. [PDF]

Matern Health Neonatol Perinatol
Lara Lona E, Buekens P, Martínez Soto J, García Ramírez JR, Chávez Saavedra G, Cienfuegos Martínez YI.   +5 more
europepmc   +1 more source